From the Headlines
News about interactions among academia, healthcare providers, and industry
Newspapers/magazines
"Free drug samples cost more in the long run." msnbc.com, 3/25/2008
"Two former Amgen salespeople allege improper drug marketing." Los Angeles Times 1/9/08
"No Pharma Funding." MeetingsNet.com, 1/1/08
"UMass policy limits doctor, drug maker ties." The Boston Globe, 12/24/07
"Drug Promotion Takes to the Web." The News & Observer, 12/05/07
"Dr. Drug Rep." New York Times 11/25/07
"Are doctors getting fees or 'bribes'? Artificial knee and hip makers settle accusations with Justice Dept." Pittsburgh Post-Gazette, 11/07/07
"Thanks, But No Thanks. Why more doctors, medical schools and hospitals are just saying no to drug-company promotions. Newsweek, 10/29/07
"Minnesota Limit on Gifts to Doctors May Catch On." New York Times, 10/12/07
"Doctor, just a little something for you. Complex sales strategies go way beyond freebies." Los Angeles Times, 8/6/07
"Lawmaker Call for Registry of Drug Firms Paying Doctors." New York Times, 8/3/07
"No easy cure: UPMC offers a smart policy on drug-firm ethics." (Editorial) Pittsburgh Post-Gazette, 7/8/2007
"Free Drug Samples?" New York Times, 5/1/07
"Court Strikes Law." New York Times, 5/1/07
"Doctors and Drug makers: A Move to End Cozy Ties." New York Times, 2/12/07
Policy initiatives:
"Draft Report of the AAMC-AAU Task Force on Industry Funding of Medical Education." www.aamc.org, 6/18/08
"Med School bans pharmaceutical freebies." Stanford Daily, 10/2/06
"U-M Health System: Drug samples, drug reps and beyond." 12/14/06
"Use of Educational Grants by Pharmaceutical Manufacturers." Prepared by the staff of the Committee on Finance, United States Senate, 4/07
"U (Minn.) to probe drug makers’ payments to doctors." Pioneer Press, 6/10/07
"Senate Bill Would Require Drug Companies to Report All Gifts to Doctors." Chronicle of Higher Education, 9/10/07
Professional journals:
"Free Drug Samples Help Wealthy Patients More Than the Needy, Study Finds" American Journal of Public Health, February 2008, Vol 98, No. 2
"Doctors and Drug Companies — Scrutinizing Influential Relationships." New England Journal of Medicine Volume 357:1796-1797, 11/1/2007 Number 18
"Physicians and Drug Representatives: Exploring the Dynamics of the Relationship." Journal of General Internal Medicine, 2/07
"Following the Script: How Drug Reps Make Friends and Influence Doctors." PLoS Medicine, 4/07
"Characteristics and Impact of Drug Detailing for Gabapentin." PLoS Medicine, 4/07
"Sunshine Laws and the Pharmaceutical Industry." Journal of the American Medical Association 2007; 297:1255-1257. {Editorial in response to original article, "Pharmaceutical Company Payments to Physicians: Early Experiences With Disclosure Laws in Vermont and Minnesota"}
"A National Survey of Physician–Industry Relationships." New England Journal of Medicine, 4/26/07
"What drug rep visits cost you." Medical Economics, 8/3/07
"Ghost Management: How Much of the Medical Literature Is Shaped Behind the Scenes by the Pharmaceutical Industry?" PLoS Medicine Vol. 4, No. 9, e286 doi:10.1371/ journal.pmed.0040286
Industry communications:
"More Than a Game of Keep Away." Pharmaceutical Executive, 5/1/06
"Selling to Hospitals: Through the Side Door." Pharmaceutical Representative, 7/1/06
"Access Restricted: Selling pharmaceuticals under the Physician Data Restriction Program." Pharmaceutical Representative, 2/1/07
Miscellaneous: